Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417869 · ClinicalTrials.gov registry record
QuickVue Influenza A + B Test Field Study
A clinical trial, sponsored by Quidel Corporation.
- Completed
- Registry status
- 1,381
- Enrollment target
NCT03417869 is a clinical trial that has completed, run by Quidel Corporation. The registered enrollment target is 1,381 participants.
The verdict
NCT03417869 has completed, sponsored by Quidel Corporation.
- COMPLETED
- Registry status
- 1,381 participants
- Enrollment target
Study Summary
Demonstrate improved clinical performance of visually read QuickVue Influenza A+B test.
Interventions
- DEVICE QuickVue Influenza A+B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,381 participants |
| Start Date | 2017-02-16 |
| Est. Completion | 2018-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03417869
The ClinicalTrials.gov registry entry for NCT03417869 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,381 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quidel Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QuickVue Influenza A+B is the first listed.
NCT03417869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03417869 about?
NCT03417869 is a clinical study titled "QuickVue Influenza A + B Test Field Study". Demonstrate improved clinical performance of visually read QuickVue Influenza A+B test.
What is the current status of trial NCT03417869?
This trial is currently completed. The enrollment target is 1,381 participants. The study started on 2017-02-16. Estimated completion is 2018-02-01.
What interventions are being tested in trial NCT03417869?
The interventions under investigation include: QuickVue Influenza A+B (DEVICE).
Who is sponsoring clinical trial NCT03417869?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.